Reneo Pharmaceuticals, Inc. announced unaudited consolidated earnings results for the second quarter and six months ended June 30, 2021. For the quarter, the company reported Loss from operations were $9,228,000 against $3,699,000 a year ago. Net loss was $9,216,000 against $3,687,000 a year ago. Net loss per share attributable to common stockholders, basic were $0.43 against $1.82 a year ago. For the six months, the company reported Loss from operations were $16,442,000 against $8,202,000 a year ago. Net loss was $16,428,000 against $8,118,000 a year ago. Net loss per share attributable to common stockholders, basic were $1.40 against $4.02 a year ago.